Suppression of KIF3B Expression Inhibits Human Hepatocellular Carcinoma Proliferation

Abstract

Background Human hepatocellular carcinoma (HCC) is one of the most common fatal cancers and an important health problem worldwide, but its mechanism is still unclear. Microtubule (MT) kinesin motor proteins orchestrate a variety of cellular processes (e.g. mitosis, motility and organelle transportation) and have been involved in human carcinogenesis. KIF3B, the kinesin superfamily of proteins (KIFs), plays an important role in the regulation of mitotic progression. Aim The expression of KIF3B and its involvement in HCC was investigated. Methods Western blot and immunohistochemistry were used to measure the expression of KIF3B protein in HCC and adjacent non-tumorous tissues in 57 patients and Cell Counting Kit-8 to analyze the effects of growth and interference of KIF3B in the cell cycle process. Results KIF3B protein level was increased in HCC tissues compared with the adjacent non-tumorous tissues. It was significantly associated with histological differentiation, tumor size, the level of alpha fetal protein (AFP) and proliferation marker Ki-67. Over-expression of KIF3B was correlated with poor survival. Following release of HepG2 cells from serum starvation, the expression of KIF3B was up-regulated. Furthermore, suppression of KIF3B not only decreased cancer cell growth but also induced apoptosis of cells.Conclusions Our results suggested that KIF3B expression was upregulated in HCC tumor tissues and proliferating HCC cells, and an increased KIF3B expression was associated with poor overall survival. KIF3B over-expression is involved in the pathogenesis of hepatocellular carcinoma and may serve as a potential therapeutic target for human HCC.

Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation

“…After 48 hours, cells were harvested with trypsin and washed 2 times in ice-cold PBS, resuspended in 100 μl of binding buffer and incubated with Annexin V-FITC (4 A Biotech, China) for 5 min at 4 °C in the dark. After staining, the cells were incubated with propidium iodide for 5 min at 4 °C in the dark and then assayed with a flow cytometer (Beckman Coulter, Germany) 42 cell cycle. Cell cycle analysis was performed with a cell cycle kit (Shanghai BestBio, China) according to the manufacture's instructions 43 .…”

KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma

“…In addition to KIF15 of this study, a variety of KIFs are reported to be involved in tumor progression. In previous studies, KIF1B, KIF3B, and KIF14 promoted growth of hepatocellular carcinoma and was correlated with the prognosis of hepatocellular carcinoma patients [24][25][26]. KIF3B was involved in the migration of seminoma cancer cells [27].…”

Protein phosphatase 1γ regulates the proliferation of human glioma via the NF-κB pathway

“…All of the stained sections were evaluated in a blinded manner by two independent senior pathologists without any clinicopathological variables of the patients (17). Five high-power fields (Leica microscope Germany) were selected randomly and >300 cells in each field were counted to determine the labeling index (LI), which means the percentage of immunostained cells relative to the total number of cells (18). Intensity was evaluated in comparison with the control and scored as follows: 0, negative staining; 1, weak staining; 2, moderate staining; 3, strong staining.…”